1. Bioequivalence of Ertugliflozin/Metformin Fixed‐Dose Combination Tablets and Coadministration of Respective Strengths of Individual Components. Issue 1 (17th June 2019) Authors: Dawra, Vikas Kumar; Liang, Yali; Wei, Hua; Pelletier, Kathleen; Shi, Haihong; Hickman, Anne; Bass, Almasa; Terra, Steven G.; Zhou, Susan; Krishna, Rajesh; Sahasrabudhe, Vaishali Journal: Clinical pharmacology in drug development Issue: Volume 9:Issue 1(2020) Page Start: 50 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Bioequivalence of Metformin in Ertugliflozin/Metformin Fixed‐Dose Combination Tablets to Canadian‐Sourced Metformin Coadministered With Ertugliflozin Under Fasted and Fed States. Issue 5 (2nd November 2020) Authors: Dawra, Vikas Kumar; Pelletier, Kathleen; Matschke, Kyle; Shi, Haihong; Hickman, Anne; Zhou, Susan; Krishna, Rajesh; Sahasrabudhe, Vaishali Journal: Clinical pharmacology in drug development Issue: Volume 10:Issue 5(2021) Page Start: 510 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Safety, Tolerability, and Pharmacokinetics of PF‐06823859, an Anti–Interferon β Monoclonal Antibody: A Randomized, Phase I, Single‐ and Multiple‐Ascending‐Dose Study. Issue 3 (22nd December 2020) Authors: Neelakantan, Srividya; Oemar, Barry; Johnson, Kristen; Rath, Natalie; Salganik, Mikhail; Berman, Gabe; Pelletier, Kathleen; Cox, Lori; Page, Karen; Messing, Dean; Tarabar, Sanela Journal: Clinical pharmacology in drug development Issue: Volume 10:Issue 3(2021) Page Start: 307 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗